100 related articles for article (PubMed ID: 25661364)
21. Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer.
Xia HH; Yang Y; Chu KM; Gu Q; Zhang YY; He H; Wong WM; Leung SY; Yuen ST; Yuen MF; Chan AO; Wong BC
Cancer; 2009 Dec; 115(23):5441-9. PubMed ID: 19685530
[TBL] [Abstract][Full Text] [Related]
22. Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas.
Liu C; Ma H; Qu L; Wu J; Meng L; Shou C
Hepatogastroenterology; 2012 Oct; 59(119):2222-7. PubMed ID: 22440249
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of serum caveolin-1 levels in gastric cancer patients.
Tas F; Karabulut S; Erturk K; Duranyildiz D
Exp Oncol; 2018 Dec; 40(4):323-327. PubMed ID: 30593761
[TBL] [Abstract][Full Text] [Related]
24. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
25. [Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].
Zhang Z; Zhao X; Lv C; Li C; Zhi F
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1548-52. PubMed ID: 23174572
[TBL] [Abstract][Full Text] [Related]
26. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
27. [Preliminary results regarding vascular endothelial growth factor (VEGF-A) levels in the serum of gastric cancer patients].
Hălmaciu I; Gurzu S; Dobreanu M; Suciu BA; Brînzaniuc K
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):446-51. PubMed ID: 23077935
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of serum leptin level in patients with gastric cancer.
Tas F; Karabulut S; Erturk K; Duranyildiz D
Eur Cytokine Netw; 2018 Jun; 29(2):52-58. PubMed ID: 30078770
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
30. Serum interleukin-6 levels reflect disease status of gastric cancer.
Wu CW; Wang SR; Chao MF; Wu TC; Lui WY; P'eng FK; Chi CW
Am J Gastroenterol; 1996 Jul; 91(7):1417-22. PubMed ID: 8678006
[TBL] [Abstract][Full Text] [Related]
31. The use of tumor markers as predictors of prognosis in gastric cancer.
Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
[TBL] [Abstract][Full Text] [Related]
32. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
[TBL] [Abstract][Full Text] [Related]
33. Preoperative serum C-reactive protein and gastric cancer; clinical-pathological correlation and prognostic significance.
Chang CC; Sun CF; Pai HJ; Wang WK; Hsieh CC; Kuo LM; Wang CS
Chang Gung Med J; 2010; 33(3):301-12. PubMed ID: 20584508
[TBL] [Abstract][Full Text] [Related]
34. [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer].
Zhu YB; Ge SH; Zhang LH; Wang XH; Xing XF; DU H; Hu Y; Li YA; Jia YN; Lin Y; Fan B; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):161-4. PubMed ID: 22368025
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients.
Spila A; Roselli M; Cosimelli M; Ferroni P; Cavaliere F; Arcuri R; Tedesco M; Carlini S; D'Alessandro R; Perri P; Casciani CU; Greiner JW; Schlom J; Guadagni F
Anticancer Res; 1996; 16(4B):2241-7. PubMed ID: 8694550
[TBL] [Abstract][Full Text] [Related]
36. Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer.
Jo JC; Ryu MH; Koo DH; Ryoo BY; Kim HJ; Kim TW; Choi KD; Lee GH; Jung HY; Yook JH; Oh ST; Kim BS; Kim JH; Kang YK
Asia Pac J Clin Oncol; 2013 Dec; 9(4):324-30. PubMed ID: 23176400
[TBL] [Abstract][Full Text] [Related]
37. Serum annexin A2 levels in acute brucellosis and brucellar spondylodiscitis.
Aktug Demir N; Kolgelier S; Sumer S; Inkaya AC; Ozcimen S; Demir LS; Ural O; Arpaci A
Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1855-9. PubMed ID: 24853056
[TBL] [Abstract][Full Text] [Related]
38. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer.
Dilege E; Mihmanli M; Demir U; Ozer K; Bostanci O; Kaya C; Aksakal O; Sakiz D
Hepatogastroenterology; 2010; 57(99-100):674-7. PubMed ID: 20698248
[TBL] [Abstract][Full Text] [Related]
40. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]